NCT06141616

Brief Summary

Although the practice of physical activity is recommended for children with asthma, the scientific literature available so far has focused mainly on improving functional capacity and quality of life. However, the effects of pulmonary rehabilitation in this population, especially in improving the level of physical activity in daily living (PADL) and activities of daily living (ADLs) have not yet been investigated in depth. Therefore, the objective of this study is to verify the effects of pulmonary rehabilitation on PADL, ADL, and other clinical outcomes of children with asthma. For this, a randomized clinical trial will be carried out that will have 2 groups: the control group (CG), which will receive only educational sessions, and the intervention group (IG) which will participate in a pulmonary rehabilitation program with supervised aerobic training performed three times a week with sessions of 60 minutes each. The total duration of interventions in both groups will be 12 weeks. The primary outcomes of this study are PADL (assessed using a physical activity monitor - Actigraph) and ADL; however, the following will also be evaluated: lung function, functional capacity, asthma control, and quality of life. We hypothesized that the performance of regular physical activity and supervised physical exercise by individuals with asthma could positively impact health outcomes with better control of asthma symptoms, better performance in ADL and PADL, and better quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

November 21, 2023

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

November 11, 2023

Last Update Submit

November 16, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Physical activity

    Number of steps per day, time spent (in minutes and percentage of the day) in light-intensity and moderate to vigorous physical activities, measured by a triaxial activity monitor.

    12 weeks from randomization

  • Sedentary behavior

    Time spent (in minutes and percentage of the day) in sedentary activities, measured by a triaxial activity monitor.

    12 weeks from randomization

  • The activity of daily living

    Time on a specific test to evaluate activities of daily living in children

    12 weeks from randomization

Secondary Outcomes (12)

  • Initial assessment about general characteristics and health status

    12 weeks from randomization

  • Pulmonary Function

    12 weeks from randomization

  • Asthma Control

    12 weeks from randomization

  • Exacerbation and medication diary

    12 weeks from randomization

  • Quality of life in asthma

    12 weeks from randomization

  • +7 more secondary outcomes

Study Arms (2)

Control group

SHAM COMPARATOR

Sessions once a week, covering information about the pathophysiology of asthma, medication instructions, self-monitoring techniques, environmental control techniques, and prevention strategies for children, adolescents, and families. They will also receive physical activity recommendations, as well as information about the importance and benefits of being physically active and maintaining a healthy lifestyle. The sessions will feature educational and playful videos, presentations, and participants will be able to clarify their doubts about the topic addressed.

Other: Asthma Rehabilitation Program

Experimental group

EXPERIMENTAL

Rehabilitation program performed 3x/week. Each session will last 60 minutes, with a minimum interval of 24 hours, for a period of three months. The main focus of the intervention is aerobic training, which will be carried out in three stages, treadmill with a warm-up (10 minutes), load (20 minutes), and cool-down (5 minutes). With an initial intensity of 65% of the maximum load obtained in the incremental shuttle walk test (ISWT). The intensity will be gradually increased up to 115%, keeping dyspnea and fatigue values between 4 and 6, according to the modified Borg scale. In addition, we will do a circuit focused on aerobic activities, maintaining target heart rate during its performance for 20 minutes. When necessary, supplemental oxygen will be provided during training. Volunteers in this group will receive a bronchodilator dose before starting each day's session. This group will hold educational sessions as well.

Other: Asthma Rehabilitation Program

Interventions

The group will receive free physiotherapy treatment with aerobic exercises, 3x/week, 60 minutes a day, lasting 3 months, in addition to educational sessions in a playful way.

Control groupExperimental group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 6 and 12 years old;
  • Clinical diagnosis of asthma, established according to the criteria of the Global Initiative for Asthma (GINA);
  • Absence of other lung diseases or signs and symptoms of other lung diseases;
  • Absence of cognitive changes;
  • Absence of signs and symptoms of gastroesophageal reflux disease and dysphagia;
  • Clinical stability according to the criteria of the Global Initiative for Asthma (GINA);

You may not qualify if:

  • Desire of the patient and/or the patient's family to discontinue participation in the study for any reason;
  • Present some new limitations that may interfere with functionality;
  • Comorbidities that prevent or contraindicate the performance of the proposed interventions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Pesquisa e Pós Graduação na Unopar

Londrina, Paraná, 86041-14, Brazil

Location

MeSH Terms

Conditions

Sedentary Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Vitória Puzzi, Msc

    Universidade Norte do Paraná

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karina Furlanetto, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 11, 2023

First Posted

November 21, 2023

Study Start

December 1, 2023

Primary Completion

March 1, 2024

Study Completion

January 1, 2025

Last Updated

November 21, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations